Patents by Inventor Yuval Shimoni

Yuval Shimoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10227559
    Abstract: The present invention provides a compounded cell culture medium powder formulation comprising: a basal medium powder and a cell culture media supplement, wherein the cell culture media supplement comprises and one or more salts; one or more growth factors; one or more inorganic ions; an amino acid supplement comprising one or more of asparagine, glutamine, histidine, and serine; one or more buffers; and one or more anti-foaming agents. The invention further provides methods of making a compounded cell culture medium powder formulation methods of making a cell culture medium for growing mammalian cells and methods of producing a protein of interest by culturing cells in the cell culture medium and isolating the protein of interest.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: March 12, 2019
    Assignee: Bayer HealthCare LLC
    Inventors: Yuval Shimoni, Volker Möhrle
  • Publication number: 20180010090
    Abstract: Formulations and methods to increase the production of recombinant proteins, and other aspects, are disclosed. The formulations and methods relate to increasing mannose or calcium concentration, or both, in a cell culture medium formulation for culturing cells that express recombinant proteins. In some embodiments, a mammalian cell culture medium formulation is provided that has at least one of mannose at about 3.5 g/L or more and calcium in a range from about 1.5 mM to about 9.5 mM. Numerous other aspects and/or embodiments are provided.
    Type: Application
    Filed: September 8, 2017
    Publication date: January 11, 2018
    Inventors: Yuval SHIMONI, Volker MÖHRLE, Venkatesh SRINIVASAN, Ricaredo MATANGUIHAN
  • Publication number: 20170191025
    Abstract: The present invention provides a compounded cell culture medium powder formulation comprising: a basal medium powder and a cell culture media supplement, wherein the cell culture media supplement comprises and one or more salts; one or more growth factors; one or more inorganic ions; an amino acid supplement comprising one or more of asparagine, glutamine, histidine, and serine; one or more buffers; and one or more anti-foaming agents. The invention further provides methods of making a compounded cell culture medium powder formulation methods of making a cell culture medium for growing mammalian cells and methods of producing a protein of interest by culturing cells in the cell culture medium and isolating the protein of interest.
    Type: Application
    Filed: April 7, 2015
    Publication date: July 6, 2017
    Applicant: Bayer HealthCare LLC
    Inventors: Yuval SHIMONI, Volker MÖHRLE
  • Publication number: 20160002592
    Abstract: Formulations and methods to increase the production of recombinant proteins, and other aspects, are disclosed. The formulations and methods relate to increasing mannose or calcium concentration, or both, in a cell culture medium formulation for culturing cells that express recombinant proteins. In some embodiments, a mammalian cell culture medium formulation is provided that has at least one of mannose at about 3.5 g/L or more and calcium in a range from about 1.5 mM to about 9.5 mM. Numerous other aspects and/or embodiments are provided.
    Type: Application
    Filed: February 25, 2014
    Publication date: January 7, 2016
    Inventors: Yuval Shimoni, Volker Moehrle, Venkatesh Srinivasan, Ricaredo Matanguihan
  • Publication number: 20150299638
    Abstract: Methods and perfusion culture systems are disclosed. The systems and methods relate to decreasing the starting perfusion rate, resulting in increased residence time of the cells in the bioreactor and the cell retention device, and/or concomitantly increasing the starting bioreactor volume or decreasing the starting cell retention device volume, or both. Other method embodiments include increasing the concentrations of individual components of the tissue culture fluid, and adding a stabilizer of the degradation of the recombinant protein.
    Type: Application
    Filed: October 9, 2013
    Publication date: October 22, 2015
    Applicant: Bayer HealthCare LLC
    Inventors: Yuval SHIMONI, Volker MOEHRLE, Venkatesh SRINIVASAN
  • Publication number: 20140099711
    Abstract: Methods and perfusion culture systems are disclosed. The systems and methods relate to decreasing the starting perfusion rate, resulting in increased residence time of the cells in the bioreactor and the cell retention device, and/or concomitantly increasing the starting bioreactor volume or decreasing the starting cell retention device volume, or both. Other method embodiments include increasing the concentrations of individual components of the tissue culture fluid, and adding a stabilizer of the degradation of the recombinant protein.
    Type: Application
    Filed: October 9, 2013
    Publication date: April 10, 2014
    Inventors: Yuval Shimoni, Volker Moehrle, Venkatesh Srinivasan